WHO SMART Guidelines - HIV
0.3.0 - ci-build
WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2024-11-07 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="HIV.C.DE17"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset"/>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset"/>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet HIV.C.DE17</b></p><a name="HIV.C.DE17"> </a><a name="hcHIV.C.DE17"> </a><a name="HIV.C.DE17-en-US"> </a><ul><li>Include these codes as defined in <a href="CodeSystem-HIVConcepts.html"><code>http://smart.who.int/hiv/CodeSystem/HIVConcepts</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE18">HIV.C.DE18</a></td><td>TDF + FTC</td><td>Treated with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)</td></tr><tr><td><a href="CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE19">HIV.C.DE19</a></td><td>TDF</td><td>Treated with single-agent tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)</td></tr><tr><td><a href="CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE20">HIV.C.DE20</a></td><td>TDF + 3TC</td><td>Treated with tenofovir disoproxil fumarate (TDF) and lamivudine (3TC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)</td></tr><tr><td><a href="CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE21">HIV.C.DE21</a></td><td>Other TDF-based regimen</td><td>Treated with other tenofovir disoproxil fumarate (TDF)-based regimen (oral PrEP)</td></tr><tr><td><a href="CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE22">HIV.C.DE22</a></td><td>Dapivirine vaginal ring (DVR)</td><td>Dapivirine vaginal ring (DVR) for HIV prevention</td></tr><tr><td><a href="CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE23">HIV.C.DE23</a></td><td>CAB-LA</td><td>Long-acting injectable cabotegravir</td></tr></table></li></ul></div>
</text>
<url value="http://smart.who.int/hiv/ValueSet/HIV.C.DE17"/>
<version value="0.3.0"/>
<name value="HIVCDE17"/>
<title value="Current PrEP regimen ValueSet"/>
<status value="active"/>
<experimental value="true"/>
<date value="2024-11-07T21:07:17+00:00"/>
<publisher value="WHO"/>
<contact>
<name value="WHO"/>
<telecom>
<system value="url"/>
<value value="http://who.int"/>
</telecom>
</contact>
<description
value="Value set of HIV pre-exposure prophylaxis (PrEP) regimen"/>
<compose>
<include>
<system value="http://smart.who.int/hiv/CodeSystem/HIVConcepts"/>
<concept>
<code value="HIV.C.DE18"/>
<display value="TDF + FTC"/>
</concept>
<concept>
<code value="HIV.C.DE19"/>
<display value="TDF"/>
</concept>
<concept>
<code value="HIV.C.DE20"/>
<display value="TDF + 3TC"/>
</concept>
<concept>
<code value="HIV.C.DE21"/>
<display value="Other TDF-based regimen"/>
</concept>
<concept>
<code value="HIV.C.DE22"/>
<display value="Dapivirine vaginal ring (DVR)"/>
</concept>
<concept>
<code value="HIV.C.DE23"/>
<display value="CAB-LA"/>
</concept>
</include>
</compose>
</ValueSet>